4th Symposium on Research andQuality Control of Vaccines
Seoul, Korea, 19-20 September 2019
Sheraton Seoul Palace Gangnam Hotel, Seoul

Co-organized byNational Institute of Food and Drug Safety Evaluation (NIFDS), Korea
National Institutes for Food and Drug Control (NIFDC), China
National Institute of Infectious Diseases (NIID), Japan

AgendaDay1

Moderator: Dr. Kwangmoon LeeTimeContents

Remarks

09:30 - 10:00

30‘

Registration

10:00 - 10:15

15‘

Welcoming remarks

10:15 - 10:25

10‘

Group photo

10:25 - 10:30

5‘

Housekeeping Announcement

Dr. Younjoo Park

Ms. Bohwa JunSession 1. Introduction of Vaccine Lot Release System in Each Country
10:30 - 10:50

20‘

National Lot Release System in Korea

Dr. Jeewon Joung(Korea)

10:50 - 11:10

20‘

Vaccine Lot Release in China

Mr. Xiao Ma (China)

11:10 – 11:30

20‘

Overview of vaccine lot release system in Japan

11:30 – 13:00

90‘

Dr. Masaki Ochiai(Japan)LunchSession 2. Vaccine Research in Each Country
13:00 - 13:30

30‘

13:30 - 14:00

30‘

The establishment of calibration sera panel forthe immunogenicity evaluation of pneumococcalvaccineThe establishment of national standard forantibodies to human papillomavirus
Improvement of rabies vaccine potency testing by

14:00 - 14:30

30‘

introduction of human endpoints and development ofin vitro assay for testing rabies vaccine inactivation

14:30 - 15:00

Ms. Eunhye Park (Korea)
Dr. Li Zhang (China)

Dr.Mutsuyo
Takayama-Ito (Japan)

coffee break

30‘

Session 3. Current Status on Alternative Testing Methods
15:00 – 15:30

30‘

Non-animal potency testing for cell-derived
inactivated JE vaccine

Dr. Naery Lee (Korea)

15:30 – 16:00

30‘

The application of reporter gene assays in thedetection of pyrogen in biologicals anddetermination of monoclonal antibody bioactivity

Dr. Chuanfei Yu(China)

Application of Systems Vaccinology for Evaluating
16:00 – 16:30

30‘

the Safety of Vaccines and Adjuvants inDr. Takuo Mizukami(Japan)Preclinical and Lot Release Tests<Reception>
17:00 – 18:30

90‘

Reception

Participants

Day2
Time

Contents

Remarks

Session 4. Introduction of countermeasures to Emerging Infectious Diseases
Study on the development of neutralization assay
09:30 – 10:00

for vaccine candidates of MERS-CoV, Zika and30‘

Mr. Hyungok Chun(Korea)

Chikungunya Viruses
Defensive measures against emerging infectious
10:00 – 10:30

30‘

diseases in Japan that has no experience of MERS

Dr. Shutoku Matsuyama(Japan)and SARS cases
Session 5. Discussion
10:30 – 11:00

Proposal for future joint studies

30‘

ParticipantsSession 6. Activities of WHO Collaborating Center in Korea, China, and Japan
11:00 – 11:20

20‘

Vaccine NRAs in Western Pacific Region

Dr. Jinho Shin (WPRO)

11:20 – 11:40

20‘

Major Achievements by NIFDS as WHO CC

Mrs. Yoonjeong Lee (Korea)

11:40 – 12:00

20‘

NIFDC’s Activities as WHO CC

Mr. Xiao Ma (China)

12:00 – 12:20

20‘

12:20 - 13:50

90‘

On-going Activities and Major Achievements byNIID as WHO CC

Dr. Koji Ishii (Japan)

Lunch

Session 7. Current Status on Vaccine National Regulatory Authorities in Asian countries
13:50 – 14:10

20‘

Vaccine NRA in the Philippines

Mr. Emerald Cafugauan

14:10 – 14:30

20‘

Current Vaccine and Biological Lot Release system
and Risk-Base elements in NCL/NICVB, Vietnam

Mr. Pham Van Hung

14:30 – 14:50

20‘

National Lot Release System in Indonesia

Mrs. Endah Eny Riayati

Session 8. Wrap-up
14:50 – 15:10

20’

Discussion on the future directions

Korea·China·Japan

15:10 – 15:15

5’

Closing Remarks

Dr. Kwangmoon Lee